Table 1.
Groups |
Treatments with dosing schedule (days) |
|||
---|---|---|---|---|
Group number (N) | Dosing | Doxorubicin | Trastuzumab | Saline |
1 (N = 7) | Control | – | – | 0, 3, 4 |
2 (N = 7) | Doxorubicin | 4 | – | 0, 3 |
3 (N = 7) | Trastuzumab | – | 0, 3 | 4 |
4 (N = 7) | Doxorubicin 24 h prior to Trastuzumab | 0 | 1, 4 | – |
5 (N = 7) | Trastuzumab 24 h prior to Doxorubicin | 4 | 0, 3 | – |
6 (N = 7) | Trastuzumab + Doxorubicin | 0, 3 | 0, 3 | – |